Evaluation of bone quality and quantity in osteoporotic mice - The effects of genistein and equol

Phytomedicine

Volumn 17, Issue 6, 2010, Pages 424-430

  Sehmisch, S ^a   Uffenorde, J ^a   Maehlmeyer, S ^a   Tezval, M ^a   Jarry, H ^a   Stuermer, K M ^a   Stuermer, E K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Biomechanical testing; Equol; Genistein; Histomorphometry; Mouse osteopenia model

Indexed keywords

EQUOL; ESTRADIOL; ESTRADIOL BENZOATE; GENISTEIN; SIGMA 1 OPIATE RECEPTOR; 4',7-DIHYDROXY-3,4-DIHYDROISOFLAVONE; BONE DENSITY CONSERVATION AGENT; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DNA MODIFICATION; FEMALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; TIBIA; ANIMAL; C57BL MOUSE; DRUG EFFECTS; PATHOLOGY; PHYTOTHERAPY;

ANIMALS; BIOMECHANICS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; ESTRADIOL; FEMALE; GENISTEIN; ISOFLAVONES; MICE; MICE, INBRED C57BL; OSTEOPOROSIS; OVARIECTOMY; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; TIBIA; BIOMECHANICAL PHENOMENA; EQUOL;

MUS;

EID: 77950023258     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.10.004     Document Type: Article

References (29)

1. Anderson J.J., and Garner S.C. Phytoestrogens and bone. Baillieres Clin. Endocrinol. Metab. 12 (1998) 543-557
2. Basly J.P., and Lavier M.C. Dietary phytoestrogens: potential selective estrogen enzyme modulators?. Planta Med. 71 (2005) 287-294
3. Bellino F.L. Nonprimate animal models of menopause: workshop report. Menopause 7 (2000) 14-24
4. Dai R., Ma Y., Sheng Z., Jin Y., Zhang Y., Fang L., Fan H., and Liao E. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J. Bone Miner. Metab. 26 (2008) 342-349
5. Fujioka M., Uehara M., Wu J., Adlercreutz H., Suzuki K., Kanazawa K., Takeda K., Yamada K., and Ishimi Y. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J. Nutr. 134 (2004) 2623-2627
6. Hegsted D.M. Calcium and osteoporosis. J. Nutr. 116 (1986) 2316-2319
7. Hertrampf T., Degen G.H., Kaid A.A., Laudenbach-Leschowsky U., Seibel J., and Di Virgilio A.L. Combined effects of physical activity, Dietary isoflavones and 17β-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med. 72 (2006) 484-487
8. Holmes P., Rumsby P., and Harrison P.T. Endocrine disrupters and menopausal health. J. Br. Menopause Soc. 10 (2004) 54-59
9. Hotchkiss C.E., Weis C., Blaydes B., Newbold R., and Delclos K.B. Multigenerational exposure to genistein does not increase bone mineral density in rats. Bone 37 (2005) 720-727
10. Humpel M., Isaksson P., Schaefer O., Kaufmann U., Ciana P., and Maggi A. Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J. Steroid Biochem. Mol. Biol. 97 (2005) 299-305
11. Iwaniec U.T., Yuan D., Power R.A., and Wronski T.J. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. J. Bone Miner. Res. 21 (2006) 1068-1074
12. Li W., Seifert M., Xu Y., and Hock B. Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environ. Int. 30 (2004) 329-335
13. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology 139 (1998) 2659-2661
14. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., and Recker R.R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2 (1987) 595-610
15. Phrakonkham P., Chevalier J., Desmetz C., Pinnert M.F., Bergès R., Jover E., Davicco M.J., Bennetau-Pelissero C., Coxam V., Artur Y., and Canivenc-Lavier M.C. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol. Appl. Pharmacol. 224 (2007) 105-115
16. Rachoń D., Seidlová-Wuttke D., Vortherms T., and Wuttke W. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas 58 (2007) 308-315
17. Rachoń D., Vortherms T., Seidlová-Wuttke D., Menche A., and Wuttke W. Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric 10 (2007) 416-426
18. Rickard D.J., Monroe D.G., Ruesink T.J., Khosla S., Riggs B.L., and Spelsberg T.C. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J. Cell Biochem. 89 (2003) 633-646
19. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., and Stefanick M.L. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2007) 321-333
20. Rowland I.R., Wiseman H., Sanders T.A., Adlercreutz H., and Bowey E.A. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer 36 (2000) 27-32
21. Sathyamoorthy N., and Wang T.T. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer 33 (1997) 2384-2389
22. Sehmisch, S., Erren, M., Rack, T., Tezval, M., Seidlova-Wuttke, D., Richter J., Wuttke, W., Stuermer, K.M., Stuermer, E.K., 2009. Short-term effects of parathyroid hormone on rat lumbar vertebrae. Spine, accepted for publication.
23. Sehmisch S., Hammer F., Christoffel J., Seidlova-Wuttke D., Tezval M., Wuttke W., Stuermer K.M., and Stuermer E.K. Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med. 74 (2008) 794-801
24. Setchell K.D., and Cole S.J. Method of defining equol-producer status and its frequency among vegetarians. J. Nutr. 136 (2006) 2188-2193
25. Sirtori C.R. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf. 24 (2001) 665-682
26. Stürmer E.K., Seidlová-Wuttke D., Sehmisch S., Rack T., Wille J., Frosch K.H., Wuttke W., and Stürmer K.M. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J. Bone Miner. Res. 21 (2006) 89-96
27. Tsuang Y.H., Chen L.T., Chiang C.J., Wu L.C., Chiang Y.F., Chen P.Y., Sun J.S., and Wang C.C. Isoflavones prevent bone loss following ovariectomy in young adult rats. J. Orthop. Surg. Res. 3 (2008) 12
28. Yamagishi T., Otsuka E., and Hagiwara H. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142 (2001) 3632-3637
29. Zeng G.Q., Cole H.W., Smith S.J., Bryant H.U., and Sato M. Bone effects in mice of ovariectomy and recombinant huan PTH (1-34) are highly strain dependent. Bone 23 (1998) 448